Literature DB >> 24390912

Behavioral therapy and serotonin reuptake inhibitor pharmacotherapy in the treatment of obsessive-compulsive disorder: a systematic review and meta-analysis of head-to-head randomized controlled trials.

Robert J Romanelli1, Frances M Wu, Ryan Gamba, Ramin Mojtabai, Jodi B Segal.   

Abstract

BACKGROUND: Effective treatments for obsessive-compulsive disorder (OCD) include behavioral therapy (exposure and response/ritual prevention and cognitive behavioral therapy) and serotonin-reuptake inhibitors (SRIs); however, the relative efficacy of these treatments is not well established. We sought to review evidence from head-to-head randomized-controlled trials (RCTs) of behavioral therapy and SRIs in the treatment of OCD.
METHODS: A systematic search of multiple databases was conducted from first available date to June 30, 2012, for RCTs in the treatment of OCD among outpatients, comparing behavioral therapy and SRIs, alone or combined. Two independent reviewers evaluated studies for eligibility and risk of bias. The main outcome measure was posttreatment mean Yale-Brown Obsessive-Compulsive Scale (YBOCS) score.
RESULTS: We identified 2,186 unique articles. Fifteen articles were included, describing 13 RCTs. Pooled standardized mean difference (SMD; 95% confidence intervals) in YBOCS score significantly favored behavioral therapy over SRIs (0.37; 0.10, 0.64; P = .007), but not in a subset of trials that used selective SRIs (0.22; -0.02, 0.47; P = .070). Within individual trials, effect sizes significantly favored the combination of behavioral therapy plus an SRI over an SRI, but not behavioral therapy, alone.
CONCLUSIONS: This review provides evidence that, among outpatients with OCD, behavioral therapy is more effective than SRIs, overall, but not selective SRIs. Furthermore, the combination of behavioral therapy plus an SRI is more effective than an SRI alone. These data may be used to inform the development of evidence-based treatment guidelines; however, more studies are also needed to further evaluate the relative efficacy of these interventions.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  behavioral therapy; cognitive behavioral therapy; exposure and response/ritual prevention; meta-analysis; obsessive-compulsive disorder; pharmacotherapy; serotonin-reuptake inhibitors; systematic review

Mesh:

Substances:

Year:  2014        PMID: 24390912     DOI: 10.1002/da.22232

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  24 in total

Review 1.  Components of Cognitive Behavioral Therapy Related to Outcome in Childhood Anxiety Disorders.

Authors:  Chelsea M Ale; Denis M McCarthy; Lilianne M Rothschild; Stephen P H Whiteside
Journal:  Clin Child Fam Psychol Rev       Date:  2015-09

2.  A META-ANALYSIS OF COGNITIVE BEHAVIOR THERAPY AND MEDICATION FOR CHILD OBSESSIVE-COMPULSIVE DISORDER: MODERATORS OF TREATMENT EFFICACY, RESPONSE, AND REMISSION.

Authors:  Joseph F McGuire; John Piacentini; Adam B Lewin; Erin A Brennan; Tanya K Murphy; Eric A Storch
Journal:  Depress Anxiety       Date:  2015-06-30       Impact factor: 6.505

3.  Psychodynamic therapy of obsessive-compulsive disorder: principles of a manual-guided approach.

Authors:  Falk Leichsenring; Christiane Steinert
Journal:  World Psychiatry       Date:  2016-10       Impact factor: 49.548

4.  Relationships between obsessive-compulsive disorder, depression and functioning before and after exposure and response prevention therapy.

Authors:  Sarosh J Motivala; Maria Arellano; Rebecca L Greco; David Aitken; Nathan Hutcheson; Reza Tadayonnejad; Joseph O'Neill; Jamie D Feusner
Journal:  Int J Psychiatry Clin Pract       Date:  2017-07-25       Impact factor: 1.812

5.  Animal Models for OCD Research.

Authors:  Brittany L Chamberlain; Susanne E Ahmari
Journal:  Curr Top Behav Neurosci       Date:  2021

Review 6.  The prefrontal cortex and neurosurgical treatment for intractable OCD.

Authors:  Steven A Rasmussen; Wayne K Goodman
Journal:  Neuropsychopharmacology       Date:  2021-08-25       Impact factor: 7.853

7.  Transient contribution of left posterior parietal cortex to cognitive restructuring.

Authors:  Chihiro Sutoh; Daisuke Matsuzawa; Yoshiyuki Hirano; Makiko Yamada; Sawako Nagaoka; Sudesna Chakraborty; Daisuke Ishii; Shingo Matsuda; Haruna Tomizawa; Hiroshi Ito; Hiroshi Tsuji; Takayuki Obata; Eiji Shimizu
Journal:  Sci Rep       Date:  2015-03-17       Impact factor: 4.379

8.  Operationalizing Cognitive Science and Technologies' Research and Development; the "Brain and Cognition Study Group (BCSG)" Initiative from Shiraz, Iran.

Authors:  Nahid Ashjazadeh; Reza Boostani; Hamed Ekhtiari; Masoumeh Emamghoreishi; Majidreza Farrokhi; Ahmad Ghanizadeh; Gholamreza Hatam; Habib Hadianfard; Mehrzad Lotfi; Seyed Mohammad Javad Mortazavi; Maryam Mousavi; Afshin Montakhab; Majid Nili; Ali Razmkon; Sina Salehi; Amir Mohammad Sodagar; Peiman Setoodeh; Mousa Taghipour; Mohammad Torabi-Nami; Abdolkarim Vesal
Journal:  Basic Clin Neurosci       Date:  2014

9.  Change in obsessive beliefs as predictor and mediator of symptom change during treatment of obsessive-compulsive disorder - a process-outcome study.

Authors:  Alice Diedrich; Philipp Sckopke; Caroline Schwartz; Sandra Schlegl; Bernhard Osen; Christian Stierle; Ulrich Voderholzer
Journal:  BMC Psychiatry       Date:  2016-07-07       Impact factor: 3.630

10.  Efficacy of Cognitive-Behavioral Therapy in Pediatric Obsessive-Compulsive Disorder: A Meta-Analysis.

Authors:  Yanqiu Wu; Zhiqiang Lang; Haitao Zhang
Journal:  Med Sci Monit       Date:  2016-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.